MBD2 and chronic myelogenous leukemia, BCR-ABL1 positive: Since the biological roles of KDMs are predominantly but not exclusively dependent on their demethylase activities, we investigated whether the demethylase activity of KDM6A is required for its protection of CML cells against imatinib.